Calcipotriol/ja: Difference between revisions
Calcipotriol/ja
Created page with "<!--Identifiers--> | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 112965-21-6 | PubChem = 5288783 | IUPHAR_ligand = 2778 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB02300 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 4450880 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = 143NQ3779B | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG..." |
Created page with "<!--Pharmacokinetic data--> | bioavailability = 5 to 6% | metabolism = Liver/ja | excretion = 胆道" Tags: Mobile edit Mobile web edit |
||
Line 66: | Line 66: | ||
}} | }} | ||
<!-- Definition and medical uses --> | <!-- Definition and medical uses --> | ||
''' | '''カルシポトリオール'''('''Calcipotriol''')は、[[vitamin D/ja|ビタミンD]]の一種である[[calcitriol/ja|カルシトリオール]]の合成[[derivative (chemistry)/ja|誘導体]]である。 [[psoriasis/ja|乾癬]]の治療に用いられる。乾癬性皮膚疾患への長期投与は安全である。 | ||
<div lang="en" dir="ltr" class="mw-content-ltr"> | <div lang="en" dir="ltr" class="mw-content-ltr"> |